A Population-Based Survey of Chronic Renal Disease in Turkey—The Credit Study
![](/xmlui/themes/Mirage2//images/mime2.png)
Date
2011Author
Süleymanlar, Gültekin
Utaş, Cengiz
Arinsoy, Turgay
Ateş, Kenan
Altun, Bülent
Altiparmak, Mehmet Riza
Ecder, Tevfik
Yilmaz, Mehmet Emin
Çamsari, Taner
Başçi, Ali
Serdengeçti, Kamil
xmlui.mirage2.itemSummaryView.MetaData
Show full item recordAbstract
Background. Chronic kidney disease (CKD) is a growing health problem worldwide that leads to end-stage kidney failure and cardiovascular complications. We aimed to determine the prevalence of CKD in Turkey, and to evaluate relationships between CKD and cardiovascular risk factors in a population-based survey., Methods. Medical data were collected through home visits and interviews. Serum creatinine, blood glucose, total cholesterol, triglycerides, HDL, LDL and uric acid were determined from 12-h fasting blood samples, and spot urine tests were performed for subjects who gave consent to laboratory evaluation., Results. A total of 10 872 participants were included in the study. The final analysis was performed on 10 748 subjects (mean age 40.5 ± 16.3 years; 55.7% women) and excluded 124 pregnant women. A low glomerular filtration rate (GFR) (< 60 mL/min/1.73 m2) was present in 5.2% of the subjects who were evaluated for GFR, while microalbuminuria and macroalbuminuria were observed in 10.2% and 2% of the subjects, respectively. The presence of CKD was assessed in subjects who gave consent for urinary albumin excretion measurement (n = 8765). The overall prevalence of CKD was 15.7%; it was higher in women than men (18.4% vs. 12.8%, P < 0.001) and increased with increasing age of the subjects. The prevalence of hypertension (32.7% in the general population), diabetes (12.7%), dyslipidaemia (76.3%), obesity (20.1%) and metabolic syndrome (31.3%) was significantly higher in subjects with CKD than subjects without CKD (P < 0.001 for all)., Conclusions. The prevalence of CKD in Turkey is 15.7%. Cardiovascular risk factors were significantly more prevalent in CKD patients.
URI
https://doi.org/10.1093/ndt/gfq656https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3107767/
http://hdl.handle.net/11655/14810